Results 251 to 260 of about 56,129 (292)
Some of the next articles are maybe not open access.
2020
Recent advances in the development of nanocarriers have started a new era in Formulation Science. Among various nanoparticles, solid lipid nanoparticles (SLNs) offer an attractive carrier system to conventional colloidal carriers, such as emulsions, microemulsions, self micro-emulsifying drug delivery system, micellar systems, liposomes, polymeric ...
Akhlesh Kumar Jain, Suresh Thareja
openaire +2 more sources
Recent advances in the development of nanocarriers have started a new era in Formulation Science. Among various nanoparticles, solid lipid nanoparticles (SLNs) offer an attractive carrier system to conventional colloidal carriers, such as emulsions, microemulsions, self micro-emulsifying drug delivery system, micellar systems, liposomes, polymeric ...
Akhlesh Kumar Jain, Suresh Thareja
openaire +2 more sources
Solid lipid nanoparticles for hydrophilic drugs
Journal of Controlled Release, 2021Hydrophilic drugs are proficient therapeutic agents however, delivery of these drugs is a difficult task. Hence, developing an efficient drug delivery system may require a multipronged approach. Colloidal drug delivery systems such as emulsions, liposomes, nanoemulsions, polymeric nanoparticles, and niosomes are known to enhance drug entrapment ...
Yashika, Mirchandani +2 more
openaire +2 more sources
Solid lipid nanoparticles for parenteral drug delivery
Advanced Drug Delivery Reviews, 2004 This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs. Firstly, different types of nanoparticles based on solid lipids such as "solid lipid nanoparticles" (SLN), "nanostructured lipid carriers" (NLC)
S A Wissing +2 more
exaly +3 more sources
Solid Lipid Nanoparticles for Drug Delivery
2023Solid lipid nanoparticles are promising carriers that allow for the delivery of poorly water-soluble drugs and have the potential to achieve sustained drug release or targeted delivery to the site of interest. Here we describe the preparation of solid lipid nanoparticles by forming a microemulsion at an elevated temperature which, upon cooling, yields ...
Wei-Chung, Luo, Xiuling, Lu
openaire +2 more sources
In vitro biocompatibility of solid lipid nanoparticles
Science of The Total Environment, 2012This study was undertaken to address the current deficient knowledge of cellular response to solid lipid nanoparticles (SLNs) exposure. We investigated the cytotoxicity of several SLNs formulations in two fibroblast cell lineages, Vero and MDCK. Several methods were used to explore the mechanisms involved in this cytotoxic process, including cell ...
Adny Henrique, Silva +4 more
openaire +2 more sources
Current Drug Delivery, 2008
The first generation of solid lipid carrier systems in nanometer range, Solid Lipid Nanoparticles (SLN), was introduced as an alternative to liposomes. SLN are aqueous colloidal dispersions, the matrix of which comprises of solid biodegradable lipids.
S S, Shidhaye +4 more
openaire +2 more sources
The first generation of solid lipid carrier systems in nanometer range, Solid Lipid Nanoparticles (SLN), was introduced as an alternative to liposomes. SLN are aqueous colloidal dispersions, the matrix of which comprises of solid biodegradable lipids.
S S, Shidhaye +4 more
openaire +2 more sources
A Review on Solid Lipid Nanoparticle
Research Journal of Pharmaceutical Dosage Forms and Technology, 2016Solid lipid nanoparticles (SLN) are the emerging field of nanotechnology having many potential applications in drug delivery as well as in research. Lipid nanoparticles offer possibility to develop new therapeutics due to their unique size dependent properties.
Amol M Patil +4 more
openaire +1 more source
2006
In the last decade of the last century, solid lipid nanoparticles (SLN) have been introduced to the literature as a novel carrier system for cosmetic active ingredients and pharmaceutical drugs. SLN consist of biodegradable physiological lipids or lipidic substances and stabilisers which are generally recognised as safe (GRAS) or have a regulatory ...
Anne Saupe, Thomas Rades
openaire +1 more source
In the last decade of the last century, solid lipid nanoparticles (SLN) have been introduced to the literature as a novel carrier system for cosmetic active ingredients and pharmaceutical drugs. SLN consist of biodegradable physiological lipids or lipidic substances and stabilisers which are generally recognised as safe (GRAS) or have a regulatory ...
Anne Saupe, Thomas Rades
openaire +1 more source
Current Drug Metabolism, 2020
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles with polymers such as chitosan greatly affects their pharmacokinetic behavior, stability, tissue uptake, and controlled drug delivery.
Nasrin Abbasi Gharibkandi +3 more
openaire +2 more sources
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles with polymers such as chitosan greatly affects their pharmacokinetic behavior, stability, tissue uptake, and controlled drug delivery.
Nasrin Abbasi Gharibkandi +3 more
openaire +2 more sources
Resveratrol in Solid Lipid Nanoparticles
Journal of Dispersion Science and Technology, 2012This article investigates the possibility of producing solid lipid nanoparticles (SLN) as protective vehicle of resveratrol, an antioxidant characterized by a fast trans-cis isomerization. SLN aqueous dispersions were produced by hot melt homogenization technique and characterized.
Carlotti ME +4 more
openaire +2 more sources